EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Beta-Blocker Use in Patients Undergoing Non-Cardiac Surgery: A Systematic Review and Meta-Analysis

Doménica Herrera Hernández, Bárbara Abreu, Tania Siu Xiao iD, Andreina Rojas, Kevin López Romero, Valentina Contreras, Sol Villa Nogueyra iD, Zulma Sosa, Samantha M Alvarez iD, Camila Sánchez Cruz, Ernesto Calderón Martinez iD

Medical Sciences · 2024

DOI: 10.3390/medsci12040064 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Medical Sciences, 2024. Verfasst von Doménica Herrera Hernández und 10 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito 170525, Ecuador. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Postoperative Complications. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The use of beta-blockers in the perioperative period has been widely investigated due to their potential to reduce the risk of major adverse cardiovascular and cerebrovascular events (MACCE) and mortality; yet their overall impact on various postoperative outcomes remains debated. This study constitutes a systematic review and meta-analysis of the impact of beta-blockers on mortality, MI, stroke, and other adverse effects such as hypotension and bradycardia in patients undergoing non-cardiac surgery.

Methods

A comprehensive systematic review and meta-analysis were conducted according to PRISMA 2020 guidelines. Searches were performed across PubMed, Cochrane, Web of Science, Scopus, EMBASE, and CINAHL databases; we included randomized controlled trials and cohort and case-control studies published from 1999 to 2024.

Results

This meta-analysis included data from 28 studies encompassing 1,342,430 patients. Perioperative beta-blockers were associated with a significant increase in stroke risk (RR 1.42, 95% CI: 1.03 to 1.97, p = 0.03, I2 = 62%). However, no statistically significant association was found between beta-blocker use and mortality (RR 0.62, 95% CI: 0.38 to 1.01, p = 0.05, I2 = 100%). Subgroup analyses revealed a protective effect on mortality for patients with high risks, such as patients with a history of atrial fibrillation, chronic heart failure, and other arrhythmias. For myocardial infarction (RR 0.82, 95% CI: 0.53 to 1.28, p = 0.36, I2 = 86%), a reduction in events was observed in the subgroup of randomized controlled trials. Beta-blockers significantly increased the risk of hypotension (RR 1.46, 95% CI: 1.26 to 1.70, p < 0.01, I2 = 25%) and bradycardia (RR 2.26, 95% CI: 1.37 to 3.74, p < 0.01, I2 = 64%).

Conclusions

Perioperative beta-blockers show increasing rates of stroke events following non-cardiac surgery but do not significantly impact the incidence of MI or mortality. The increased risks of hypotension and bradycardia necessitate careful patient selection and monitoring. Future research should aim to refine patient selection criteria and optimize perioperative management to balance the benefits and risks of beta-blocker use in surgical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic beta-AntagonistsPostoperative ComplicationsHumansStrokeHypotensionSurgical Procedures, OperativeBradycardiaMyocardial Infarction

Stichwörter der Autor:innen

bradycardiacardiovascular outcomeshypotensionmortalitymyocardial infarctionnon-cardiac surgeryperioperative beta-blockersstroke

Substanzen

Adrenergic beta-Antagonists

Autor:innen und Institutionen

  • Facultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito 170525, Ecuador.
  • Facultad de Medicina, Universidad de Carabobo, Valencia 2005, Venezuela.
  • Radiology Department, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Facultad de Medicina, Universidad de Oriente, Núcleo Anzoátegui, Barcelona 6001, Venezuela.
  • Facultad de Medicina, Universidad del Salvador, San Salvador 1101, El Salvador.
  • Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX 77030, USA.

ORCID-Profile: Tania Siu Xiao, Sol Villa Nogueyra, Samantha M Alvarez, Ernesto Calderón Martinez

Zitieren

APA

Herrera Hernández, D., Abreu, B., Xiao, T. S., Rojas, A., Romero, K. L., Contreras, V., Nogueyra, S. V., Sosa, Z., Alvarez, S. M., Sánchez Cruz, C., & Calderón Martinez, E. (2024). Beta-Blocker Use in Patients Undergoing Non-Cardiac Surgery: A Systematic Review and Meta-Analysis. Medical Sciences. https://doi.org/10.3390/medsci12040064

Vancouver

Herrera Hernández D, Abreu B, Xiao TS, Rojas A, Romero KL, Contreras V, et al. Beta-Blocker Use in Patients Undergoing Non-Cardiac Surgery: A Systematic Review and Meta-Analysis. Medical Sciences. 2024. doi:10.3390/medsci12040064

BibTeX
@article{HerreraHernndez2024,
  author = {Herrera Hernández, Doménica and Abreu, Bárbara and Xiao, Tania Siu and Rojas, Andreina and Romero, Kevin López and Contreras, Valentina and Nogueyra, Sol Villa and Sosa, Zulma and Alvarez, Samantha M and Sánchez Cruz, Camila and Calderón Martinez, Ernesto},
  title = {Beta-Blocker Use in Patients Undergoing Non-Cardiac Surgery: A Systematic Review and Meta-Analysis},
  journal = {Medical Sciences},
  year = {2024},
  doi = {10.3390/medsci12040064}
}
Kostenlos starten →